Author Details

Radecka, Barbara

  • Vol 7, Supp. A (2011) - CASE REPORT
    Kontrowersje dotyczące radiologicznej oceny odpowiedzi na leczenie u chorej na rozsianego raka piersi z nadmierną ekspresją HER2 leczonej lapatynibem z kapecytabiną — rola współpracy radiologa i klinicysty
    Details  PDF (Polish)
  • Vol 7, Supp. C (2011) - CASE REPORT
    Zastosowanie ewerolimusu w czwartej linii leczenia u chorego z zaawansowanym rakiem nerki
    Abstract  PDF (Polish)
  • Vol 7, Supp. C (2011) - CASE REPORT
    Zastosowanie ewerolimusu w trzeciej lini leczenia u chorego z zaawansowanym rakiem nerki
    Abstract  PDF (Polish)
  • Vol 8, No 2 (2012) - REVIEW ARTICLES
    Patients compliance, adherence and persistance is associated with effectiveness of oral therapies
    Abstract  PDF (Polish)
  • Vol 10, No 3 (2014) - CASE REPORTS
    Small cell lung cancer — case report
    Abstract  PDF (Polish)
  • Vol 10, Supp. C (2014) - CASE REPORT
    Complete response during treatment with abiraterone in castration-resistant prostate cancer — case report
    Abstract  PDF (Polish)
  • Vol 12, No 6 (2016) - ORIGINAL ARTICLES
    Carcinoembryonic antigen assessment during the perioperative period in patients with colorectal cancer in Poland
    Abstract  PDF
  • Vol 15, No 2 (2019) - ORIGINAL ARTICLE
    Consistency in biomarkers expression between matched tissue microarray cores from primary gallblader and ovarian cancers
    Abstract  PDF
  • Vol 16, No 2 (2020) - STANOWISKO EKSPERTÓW (EXPERTS' OPINION)
    Systemic treatment of patients with solid tumors during the COVID-19 (SARS-CoV-2) pandemic — comprehensive recommendations of the Polish Society of Clinical Oncology
    Details  PDF
  • Vol 17, No 1 (2021) - CASE REPORT
    Invasive breast cancer in ectopic axillary breast tissue — case report
    Abstract  PDF
  • Vol 17, No 2 (2021) - REVIEW ARTICLES
    Quality of life of patients with advanced pancreatic cancer
    Abstract  PDF
  • Vol 18, No 3 (2022) - COMMENTARY
    Commentary to Effect of ribociclib plus fulvestrant on overall survival in the treatment of advanced breast cancer — updated MONALEESA-3 results
    Details  PDF  HTML
  • Vol 19, No 4 (2023) - ORIGINAL ARTICLES
    Chemotherapy compliance in elderly patients with solid tumors: a real-world clinical practice data
    Abstract  PDF  HTML
  • Vol 19, No 1 (2023) - CASE REPORTS
    Stevens-Johnson syndrome in breast cancer patient treated with ribociclib
    Abstract  PDF  HTML
  • Vol 18, No 5 (2022) - REVIEW ARTICLES
    Advanced pancreatic cancer: diagnosis and systemic treatment evolution over the last decades
    Abstract  PDF  HTML
  • Vol 19, No 6 (2023) - ORIGINAL ARTICLES
    Survival of pancreatic cancer patients treated with nab-paclitaxel (nab-P) in clinical practice: analysis of National Health Fund data
    Abstract  PDF  HTML
  • Vol 20, No 2 (2024) - ORIGINAL ARTICLES
    Home-based treatment with subcutaneous trastuzumab: safe and acceptable not only during a pandemic — final analysis of the RWD project ‘FlexCare’
    Abstract  PDF
  • Vol 19, No 3 (2023) - REVIEW ARTICLES
    Immunotherapy for gastroesophageal cancer
    Abstract  PDF  HTML
  • Vol 19, No 3 (2023) - REVIEW ARTICLES
    Immunotherapy for colorectal cancer
    Abstract  PDF  HTML
  • Ahead of print - COMMENTARY
    Commentary on Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience
    Details  PDF
  • Ahead of print - ORIGINAL ARTICLES
    Systemic treatment of patients with advanced pancreatic cancer — is there still a place for gemcitabine in the first-line setting? Experience of Polish oncology centers
    Abstract  PDF
  • Ahead of print - ORIGINAL ARTICLES
    Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index as clinical predictive and prognostic markers in patients with advanced pancreatic cancer receiving gemcitabine monotherapy
    Abstract  PDF
  • Ahead of print - ORIGINAL ARTICLES
    Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience
    Abstract  PDF

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl